Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Sclerosis
Related studies linked through entity extraction aliases.
High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Multiple Sclerosis With Copaxone and Albuterol
- Status
- COMPLETED
- Phase
- NA
Auditory Function in Patients With and Without Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.
- Status
- WITHDRAWN
- Phase
- PHASE4
Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis
- Status
- TERMINATED
- Phase
- PHASE2
Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1
Rolipram to Treat Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Yoga: Effect on Attention in Aging & Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Natural Antioxidants in the Treatment of Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple Sclerosis
- Status
- UNKNOWN
- Phase
- N/A
A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
Zenapax to Treat Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS)
- Status
- COMPLETED
- Phase
- PHASE2
A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
- Status
- RECRUITING
- Phase
- N/A